Vivimed Labs IPO
Vivimed Labs IPO — date, price band, lot size & details 2005
Vivimed Labs listed on 17 Aug 2005 at ₹131, 87.1% above the ₹70 issue price.
Vivimed Labs is a Hyderabad based maker of specialty ingredients for the personal care industry. Its total income was Rs 41.16 crore in FY2004.
Stock price
Vivimed Labs is listed — here is the live share price.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Timetable
Key dates from opening to listing. Today is 12 November.
- Open 09 Jul 2005
- Close 13 Jul 2005
- Allotment 05 Aug 2005
- Refund/credit TBA
- Listing 17 Aug 2005
Issue summary
The terms of the offer, as filed.
| IPO Dates | 9 to 13 Jul, 2005 |
|---|---|
| Price Band | TBA |
| Face Value | ₹10 |
| Lot Size | 100 Shares |
| Issue Size | ₹17.51 Cr |
| Sale Type | Fresh capital only |
| Listing On | BSE, NSE |
| Registrar | Aarthi Consultants Pvt.Ltd. |
| Min Investment | ₹ 7,000 |
Share of the offer set aside for each investor category, as stated in the offer document.
What will it cost me?
Bidding is in multiples of 100 shares at the ₹70 cut-off. Drag to size your application.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 100 | ₹7,000 |
| Retail (max) | 28 | 2,800 | ₹1,96,000 |
| S-HNI (min) | 29 | 2,900 | ₹2,03,000 |
| S-HNI (max) | 142 | 14,200 | ₹9,94,000 |
| B-HNI (min) | 143 | 14,300 | ₹10,01,000 |
Strengths & risks
Drawn from the offer document — the case for and against, side by side.
Strengths · 4
- 01Total income rose from Rs 30.95 crore in FY2003 to Rs 41.16 crore in FY2004.
- 02Profit after tax rose from Rs 3.48 crore in FY2003 to Rs 4.00 crore in FY2004.
- 03Net worth rose from Rs 12.04 crore in FY2003 to Rs 20.80 crore in FY2005.
- 04Reserves rose from Rs 6.84 crore in FY2003 to Rs 15.57 crore in FY2005.
Risks · 5
- 01Its business depends on a narrow niche, ingredients for personal care makers; total income was Rs 41.16 crore in FY2004.
- 02Its exports depend on stable policies in India and buyer countries, as disclosed in the prospectus; net worth was Rs 20.80 crore.
- 03Its financial figures come from a SEBI filing made months before the issue; FY2005 income is not shown.
- 04It is a small company raising Rs 17.51 crore.
- 05Promoter holding fell from 55.13% before the issue to 36.14% after it.
Three years of numbers
All figures in ₹ crore, as reported in the Vivimed Labs offer document.
| Metric | 31 Mar 2005 | 31 Mar 2004 | 31 Mar 2003 |
|---|---|---|---|
| Total Income | - | 41.16 | 30.95 |
| Profit After Tax | - | 4.00 | 3.48 |
| NET Worth | 20.80 | 15.99 | 12.04 |
| Reserves and Surplus | 15.57 | 10.76 | 6.84 |
See how this IPO compares — view listing performance of all mainboard IPOs.
Valuation & key ratios
Ratios are for the latest full financial year reported in the Vivimed Labs RHP.
Where the money goes
₹26.50 Cr of the issue is earmarked to named objects.
About the company
It makes ingredients used in the personal care industry.
A group company, VVS Pharmaceuticals, makes pharmaceutical formulations such as tablets, capsules, syrups and injectables.
The IPO was Rs 17.51 crore and was entirely a fresh issue at Rs 70 per share, with a face value of Rs 10.
Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.
040-27638111/27638111/27638111
The bankers & the filings
Who is running the book, and the documents this page is built from.
Vivimed Labs IPO Documents
Read the filings this page is built from.
Lead Manager Track Record
How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.
Standard Chartered Securities (India) Ltd
24 issues handledBest listing: Saamya Biotech (India) (+75.0%). Weakest: Abhishek Mills (-14.9%).
Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.
Company contact
Frequently asked
What is the GMP of Vivimed Labs?
The current Grey Market Premium is ₹0.
What is the Vivimed Labs IPO price band?
₹70, on a face value of ₹10.
When is the allotment?
The basis of allotment is 5 August 2005, with listing on 17 August 2005.
How do I check allotment status?
On the IPO Guru allotment page or on the registrar's site — Aarthi Consultants Pvt.Ltd..
Every number here traces back to a filing.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Every number on this page is sourced from the RHP, BSE & NSE.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
